Literature DB >> 8858429

Entry to care: positive choice or fait accompli? developing a more proactive nursing response to the needs of older people and their carers.

M Nolan1, G Walker, J Nolan, S Williams, F Poland, M Curran, B C Kent.   

Abstract

A range of issues surrounding admission to either residential or nursing home care are considered from the perspectives of older people and their family carers. Drawing on the literature and a number of studies conducted by the authors, the processes and perceptions that shape and influence admission to care are identified. On the basis of the interaction of these factors a four-stage typology of admission is suggested: the positive choice, the rationalized alternative, the discredited option, and the fait accompli. The characteristics of each admission type are discussed and the implications for professionals, particularly nurses, working with older people and their carers are addressed.

Entities:  

Mesh:

Year:  1996        PMID: 8858429     DOI: 10.1046/j.1365-2648.1996.01966.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  3 in total

1.  When Frail Older People Relocate in Very Old Age, Who Makes the Decision?

Authors:  Fiona Scheibl; Morag Farquhar; Jackie Buck; Stephen Barclay; Carol Brayne; Jane Fleming
Journal:  Innov Aging       Date:  2019-09-06

2.  The experience of transitions in care in very old age: implications for general practice.

Authors:  Fiona Scheibl; Jane Fleming; Jackie Buck; Stephen Barclay; Carol Brayne; Morag Farquhar
Journal:  Fam Pract       Date:  2019-11-18       Impact factor: 2.267

3.  "Please listen to me": A cross-sectional study of experiences of seniors and their caregivers making housing decisions.

Authors:  Rhéda Adekpedjou; Dawn Stacey; Nathalie Brière; Adriana Freitas; Mirjam M Garvelink; Stéphane Turcotte; Matthew Menear; Henriette Bourassa; Kimberley Fraser; Pierre J Durand; Serge Dumont; Lise Roy; France Légaré
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.